Gw Pharma

Developer of cannabinoid medicines for MS spasticity, cancer pain and childhood epilepsy

placeCambridge, England, United Kingdom calendar_todayFounded 1998 groups326 employees language gwpharm.com

Registered entities

Investor mix

8 investors on record.

Investor typeCountShare
Venture capital338%
Private equity338%
Bank & private debt113%
Other / undisclosed113%
Coming soon